Blackpool woman recovered from Covid-19 and pneumonia - two weeks later she had a stroke I had an intense pain in my head, the room was spinning and I couldn’t stop being sick.
05:00, 29 APR 2021
Updated I woke up two weeks after leaving hospital feeling completely disorientated (Image: Submitted)
Cut through the noise and get the Lancashire news to your inbox for free - twice dailyInvalid EmailSomething went wrong, please try again later.
Subscribe
When you subscribe we will use the information you provide to send you these newsletters. Your information will be used in accordance with ourPrivacy Notice.
Thank you for subscribingWe have more newslettersShow meSee ourprivacy notice
Racism on the frontline: Britain s Asian healthcare workers | Coronavirus pandemic News aljazeera.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from aljazeera.com Daily Mail and Mail on Sunday newspapers.
Four thousand UK volunteers needed for latest COVID-19 vaccine study Published:
4,000 volunteers are set to be recruited to the latest vaccine study running in the UK, examining a new COVID-19 vaccine candidate.
Developed by specialty vaccine company Valneva, the vaccine is being manufactured at the company’s site in Livingston, West Lothian. It is the only inactivated, adjuvanted (an ingredient to create a strong immune response) COVID-19 vaccine in clinical development in Europe.
The study will be running across 22 National Institute for Health Research (NIHR) sites in England, and two sites in Scotland, and is open to healthy adults who have not had a previous COVID-19 vaccine.
Does Covid lead to a greater risk of strokes? A woman from Witherley shares her story of having both leicestermercury.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leicestermercury.co.uk Daily Mail and Mail on Sunday newspapers.
Faltering vaccine supplies in India is bad news for the world
The world’s biggest vaccine producer is running out of Covid-19 shots as it struggles to keep pace with a huge surge in new infections.
India typically produces more than 60% of all vaccines sold globally, and is home to the Serum Institute of India (SII), the globe’s largest vaccine maker.
This vast manufacturing capability is why the country is a major player in COVAX, the global vaccine-sharing initiative that provides discounted or free doses for lower-income countries.
Under an initial agreement announced last year, the SII would manufacture up to 200 million doses for up to 92 countries. But the situation in India has changed dramatically since then, Jessie Yeung and Esha Mitra write.